FDA Panel: No Changes Needed for fall COVID Boosters | NewsDirectory3 Key Points FDA panel advises using the JN.1 strain for fall COVID boosters. Panelists express concern over potential delays from new trial requirements. COVID-19 remains a risk, especially for older adults and young children. Vaccine uptake remains low despite proven effectiveness. Updated labels warn … Read more
Following a spike in Covid-19 in Southeast Asia, India has also seen fresh cases of Covid-19 in recent weeks, with most cases being reported from Kerala, Maharashtra, Gujarat and Tamil Nadu. However, most of the cases are mild and not associated with severity or mortality. “So far cases have been sporadic. The JN.1 sub-variant of … Read more
The COVID-19 pandemic had a significant impact on mental health, increasing depression, anxiety, and stress. WHO reported a 25% rise in the global prevalence of anxiety and depression worldwide in 2020 [12]. Before the COVID-19 pandemic, mental health challenges among adolescents and young adults were already a significant global concern [13,14,15], while this problem may … Read more
At its first meeting under the new administration, the US Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) voted on recommendations for several vaccines but did not vote on the influenza vaccine, as had previously been scheduled. ACIP was due to meet in February, as it does annually, but the … Read more
A study from the prestigious Yale University School of Medicine has described the chronic symptoms that developed and persisted for some individuals soon after receiving a COVID-19 vaccine as a previously-unrecognised condition they named post-vaccination syndrome (PVS). The new study, a preprint (which means it has not yet been peer-reviewed) says the symptoms include excessive … Read more
TOPLINE: Treatment with Paxlovid in older adults did not appear to make a difference in whether or not they were hospitalized because of COVID-19. METHODOLOGY: Over a 9-month time span starting in April 2022, researchers analyzed the hospital data of over 1.6 million Ontario residents aged 65 to 74 years. Nearly 88% of all patients … Read more
People with vasculitis may need at least three or four vaccinations for COVID-19 before they start to show an immune response against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, new research has suggested. In a longitudinal retrospective study, serum antibody neutralization against the Omicron variant of the virus and its descendants was found to … Read more
How long will vaccine protection last? A simple blood test may have the answer. Researchers at Stanford School of Medicine, Stanford, California, have identified a molecular signature in the blood that appears days after vaccination and predicts the durability of the immune response. Published in Nature Immunology in January, this discovery could transform vaccine development, … Read more
FDA Approves Updated Novavax COVID-19 Vaccine As one of the more important vaccine approvals since the very first COVID-19 vaccine was introduced to older adults, in September of 2024, the FDA approved Novavax’s updated COVID-19 vaccine. Designed with a monovalent component corresponding to the Omicron variant JN.1 strain, this formula was approved for protecting individuals … Read more